Phytoplant | Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors.

Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors.

Introducción

Recent approved medicines whose active principles are Δ9Tetrahidrocannabinol (Δ9-THC) and/or cannabidiol (CBD) open novel perspectives for other phytocannabinoids also present in Cannabis sativa L. varieties. Furthermore, solid data on the potential benefits of acidic and varinic phytocannabinoids in a variety of diseases are already available. Mode of action of cannabigerol (CBG), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), cannabidivarin (CBDV) and cannabigerivarin (CBGV) is, to the very least, partial.

Cannabinoid CB1 or CB2 receptors, which belong to the G-protein-coupled receptor (GPCR) family, are important mediators of the action of those cannabinoids. Pure CBG, CBDA, CBGA, CBDV and CBGV from Cannabis sativa L. are differentially acting on CB1 or CB2 cannabinoid receptors.

Materiales y métodos

CBD and CBDA was purified from the Cannabis variety SARA (CPVO/20150098), CBG and CBGA from the variety AíDA (CPVO/20160167). CBDV from the variety THERESA (CPVO/20160116), CBGV from the variety JUANI (CPVO/20160117) and Δ9-THC from the variety MONIEK (CPVO/20160114) following a patented method described in the Phytoplant Patents: “Methods of purifying cannabinoids, compositions and kits thereof” with code 9765000 B2 and “Methods of purifying cannabinoids using liquid: liquid chromatography” with code 10207199 B2. All the cannabinoids have a purity > 95%. CANNA products were used for the cultivation of all varieties.

Resultados

Affinity of cannabinoids depend on the ligand of reference and may be different in membranes and in living cells. All tested phytocannabinoids have agonist-like behavior but behaved as inverse-agonists in the presence of selective receptor agonists. CBGV displayed enhanced potency in many of the functional outputs. However, the most interesting result was a biased signaling that correlated with differential affinity, i.e., the overall results suggest that the binding mode of each ligand leads to specific receptor conformations underlying biased signaling outputs.

Conclusión

Results here reported and the recent elucidation of the three-dimensional structure of CB1 and CB2 receptors help understanding the mechanism of action that might be protective and the molecular drug-receptor interactions underlying biased signaling.

Ir a la publicación

Otras publicaciones

First Report of Charcoal Rot Caused by Macrophomina phaseolina on Hemp (Cannabis sativa L.) Varieties Cultivated in Southern Spain

Development of ornamental Cannabis sativa L. cultivars: phytochemical, morphological, genetic characterization and propagation aspects

Influence of media composition and genotype for successful Cannabis sativa L. in vitro introduction

Yield of new hemp varieties for medical purposes in a semi-arid Mediterranean environment (Spain)

Cannabinoids and terpenoids yields of the ornamental Cannabis sativa L. cultivar ‘Divina’ characterized by a variegated foliage as morphological marker

Cannabidiol Prevents the Expression of the Locomotor Sensitization and the Metabolic Changes in the Nucleus Accumbent and Prefrontal Cortex Elicited by the Combined Administration of Cocaine and Caffeine in Rats.

Impact of Plant Density and Irrigation on Yield of Hemp (Cannabis sativa L.) in a Mediterranean Semi-arid Environment

Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors.

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes.

Seeking suitable agronomical practices for industrial hemp (Cannabis sativa L.) cultivation for biomedical applications.

Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes.

Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists

Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids

The potential of near infrared spectroscopy to estimate the content of cannabinoids in Cannabis sativa L.: A comparative study.

Untargeted characterization of extracts from Cannabis sativa L. cultivars by gas and liquid chromatography coupled to mass spectrometry in high resolution mode.

A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors.

Exploring the mysteries of cannabis through gas chromatography

Biological Activity of Cannabis sativa L. Extracts Critically Depends on Solvent Polarity and Decarboxylation.

Thermal desorption-ion mobility spectrometry: A rapid sensor for the detection of cannabinoids and discrimination of Cannabis sativa L. chemotypes

Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors

Politica de Calidad

Ayudas de la Unión Europea para el autoconsumo fotovoltaico

Otros servicios

Material vegetal

Consulta nuestro catálogo varietal.

Asistencia técnica

Experiencia y rigor científico para acompañarte en tu proyecto.

Tecnología licenciable

Utiliza nuestras variedades y procesos tecnológicos patentados.

Investigación

I+D+i en cultivo, hibridación y extracción.

Solicita información

¿Te podemos ser de ayuda? ¿Tienes alguna duda sobre nosotros? Escríbenos y contactaremos contigo cuanto antes.

Para habilitar el envío de mensajes desde el sitio web necesitamos que acepte las cookies técnicas, ya que usamos reCAPTCHA 3 de Google para evitar el envío de mensajes por parte de bots fraudulentos.

Aceptar el uso de cookies técnicas